![](https://d3ilqtpdwi981i.cloudfront.net/6JUbQrZ1aVXvVUCadKTdDMmAStY=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/0b/33/7f/0b337fd7-ed22-4c4c-879f-473b1a382e2c/thumbnail_cc0f282d-5e02-4f33-a325-1cab5979ab8d.jpg)
Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benzodiazepines long-term without ever receiving evidence-based first-line treatments (e.g., psychotherapy, relaxation techniques, sleep hygiene education, serotonergic agents). This review discusses the risks and benefits of, and alternatives to benzodiazepines. We discuss evidence-based indications and contraindications, and the theoretical biopsychosocial bases for effectiveness, ineffectiveness and harm. Potential adverse effects and drug-drug interactions are summarized. Finally, both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed. Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation.
Available at: http://works.bepress.com/brian-merrill/3/